These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 17203162)

  • 1. Expression levels of eIF4E, VEGF, and cyclin D1, and correlation of eIF4E with VEGF and cyclin D1 in multi-tumor tissue microarray.
    Yang SX; Hewitt SM; Steinberg SM; Liewehr DJ; Swain SM
    Oncol Rep; 2007 Feb; 17(2):281-7. PubMed ID: 17203162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of cyclin D1 and vascular endothelial growth factor(VEGF) in non-small cell lung carcinoma and their association with the prognosis].
    Liang RY; Liao ZS; Jiang SP; Zhang W; Li JG; Zheng DH
    Ai Zheng; 2003 Jan; 22(1):86-90. PubMed ID: 12561444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eukaryotic initiation factor 4E variants alter the morphology, proliferation, and colony-formation properties of MDA-MB-435 cancer cells.
    Goldson TM; Vielhauer G; Staub E; Miller S; Shim H; Hagedorn CH
    Mol Carcinog; 2007 Jan; 46(1):71-84. PubMed ID: 17091471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Myc-dependent apoptosis by eukaryotic translation initiation factor 4E requires cyclin D1.
    Tan A; Bitterman P; Sonenberg N; Peterson M; Polunovsky V
    Oncogene; 2000 Mar; 19(11):1437-47. PubMed ID: 10723135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eukaryotic initiation factor-4E and cyclin D1 expression associated with patient survival in lung cancer.
    Khoury T; Alrawi S; Ramnath N; Li Q; Grimm M; Black J; Tan D
    Clin Lung Cancer; 2009 Jan; 10(1):58-66. PubMed ID: 19289374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. eIF4E--from translation to transformation.
    Mamane Y; Petroulakis E; Rong L; Yoshida K; Ler LW; Sonenberg N
    Oncogene; 2004 Apr; 23(18):3172-9. PubMed ID: 15094766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylation of the eukaryotic translation initiation factor eIF4E contributes to its transformation and mRNA transport activities.
    Topisirovic I; Ruiz-Gutierrez M; Borden KL
    Cancer Res; 2004 Dec; 64(23):8639-42. PubMed ID: 15574771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Translational control of malignancy: the mRNA cap-binding protein, eIF-4E, as a central regulator of tumor formation, growth, invasion and metastasis.
    Zimmer SG; DeBenedetti A; Graff JR
    Anticancer Res; 2000; 20(3A):1343-51. PubMed ID: 10928042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. eIF4E activation is commonly elevated in advanced human prostate cancers and significantly related to reduced patient survival.
    Graff JR; Konicek BW; Lynch RL; Dumstorf CA; Dowless MS; McNulty AM; Parsons SH; Brail LH; Colligan BM; Koop JW; Hurst BM; Deddens JA; Neubauer BL; Stancato LF; Carter HW; Douglass LE; Carter JH
    Cancer Res; 2009 May; 69(9):3866-73. PubMed ID: 19383915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. eIF-4E expression and its role in malignancies and metastases.
    De Benedetti A; Graff JR
    Oncogene; 2004 Apr; 23(18):3189-99. PubMed ID: 15094768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eukaryotic initiation factor 4E (eIF4E) and angiogenesis: prognostic markers for breast cancer.
    Zhou S; Wang GP; Liu C; Zhou M
    BMC Cancer; 2006 Sep; 6():231. PubMed ID: 17010208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells.
    Dong K; Wang R; Wang X; Lin F; Shen JJ; Gao P; Zhang HZ
    Breast Cancer Res Treat; 2009 Feb; 113(3):443-56. PubMed ID: 18327707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 4E-BP3 regulates eIF4E-mediated nuclear mRNA export and interacts with replication protein A2.
    Chen CC; Lee JC; Chang MC
    FEBS Lett; 2012 Jul; 586(16):2260-6. PubMed ID: 22684010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of 4E-BP1 sensitizes U87 glioblastoma xenograft tumors to irradiation by decreasing hypoxia tolerance.
    Dubois L; Magagnin MG; Cleven AH; Weppler SA; Grenacher B; Landuyt W; Lieuwes N; Lambin P; Gorr TA; Koritzinsky M; Wouters BG
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1219-27. PubMed ID: 19251093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of eukaryotic initiation factor 4E predicts clinical outcome in patients with mantle cell lymphoma treated with hyper-CVAD and rituximab, alternating with rituximab, high-dose methotrexate, and cytarabine.
    Inamdar KV; Romaguera JE; Drakos E; Knoblock RJ; Garcia M; Leventaki V; Medeiros LJ; Rassidakis GZ
    Cancer; 2009 Oct; 115(20):4727-36. PubMed ID: 19708031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression and Significance of BP1 Gene and Cyclin D1 Gene in Breast Cancer].
    Song YC; Fu SD; Wen XP; Ma ZH; Dang CX
    Ai Zheng; 2007 Jul; 26(7):709-14. PubMed ID: 17626745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical expression of vascular endothelial growth factor and vascular endothelial growth factor receptor associated with tumor cell proliferation in canine cutaneous squamous cell carcinomas and trichoepitheliomas.
    Al-Dissi AN; Haines DM; Singh B; Kidney BA
    Vet Pathol; 2007 Nov; 44(6):823-30. PubMed ID: 18039895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium arsenite-induced inhibition of eukaryotic translation initiation factor 4E (eIF4E) results in cytotoxicity and cell death.
    Othumpangat S; Kashon M; Joseph P
    Mol Cell Biochem; 2005 Nov; 279(1-2):123-31. PubMed ID: 16283521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of endothelial PAS domain protein 1 and hypoxia inducible factor 1alpha on vascular endothelial growth factor expression in human pancreatic carcinoma.
    Zhu DM; Li DC; Zhang ZX; Zhang XY
    Chin Med J (Engl); 2008 Nov; 121(22):2258-64. PubMed ID: 19080330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the eukaryotic translation initiation factor 4E for cancer therapy.
    Graff JR; Konicek BW; Carter JH; Marcusson EG
    Cancer Res; 2008 Feb; 68(3):631-4. PubMed ID: 18245460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.